期刊文献+

探讨高血压的病因及临床治疗 被引量:16

探讨高血压的病因及临床治疗
下载PDF
导出
摘要 目的分析高血压的病因构成特点及临床治疗方法。方法回顾性分析2009年1月~2011年12月心血管内科2213例高血压患者病因分布情况及针对不同病因采取的治疗措施。结果 2213例高血压患者中原发性高血压为1472例,继发性高血压741例;741例继发性高血压中,以睡眠呼吸暂停综合征、原发性醛固酮增多症及肾实质性高血压为病因的患者所占的比例相对较大;根据2213例患者的不同情况,采取不同的治疗措施,治疗总有效率为90.01%。结论根据高血压患者的不同情况,采取不同的治疗措施,提高防治水平,对控制高血压具有重要的意义。 Objective Analysis the etiology and treatment of high blood pressure.Methods Retrospective analysis 2213 cases hypertension patients' distribution of pathogenesis and treatment measures.Results There were 1472 patients with essential hypertension and 741 patients with secondary hypertension.The Highest prevalence rate of secondary hypertension was sleep apnea Syndrome,the following were PA and renal hypertension.After treatment,the total effective rate was 90.01%.Conclusion It has the important significance that take different treatment measures based on cause.
作者 王翠霞
出处 《当代医学》 2012年第17期93-94,共2页 Contemporary Medicine
关键词 高血压 病因 High blood pressure Etiology
  • 相关文献

参考文献7

二级参考文献15

  • 1陶萍.硝苯地平控释片的制剂特点[J].中华心血管病杂志,1994,22(5):326-327. 被引量:20
  • 2麻连荣.老年人抗高血压药物的选择应用[J].中国医药导报,2007,4(08Z):168-168. 被引量:3
  • 3Degli EE, Berto P, Ruffo P, et al. The PANDORA project: result of the cost of illness analysi. J Hum Hypertents. 2001. 15:329-334.
  • 4Degli EE, Sturani A, Degli EL, et al. Pharmacoutilization of antihypertensive drugs: a model of analysis. Int J Clin Pharmacol Ther ,2001,39:251-258.
  • 5Johannesson M, Dahlof B, Lintholm LH, et al. The cost-effectiveness of treating hypertension in elderly people-an analysis of the Swedish TrialOld Patients with Hypertension (STOP Hypertension). J Intern Med ,1993,234 : 317-323.
  • 6Cost effectiveness of combination therapy. Based on a presentation by Daniel Hilleman, Pharm D. Am J Manag Care , 1999, 5( Suppl 7):S449-454.
  • 7Dunn EC, Small RE. Economic of antihypertensive therapy in the elderly. Drugs Anging ,2001, 18: 515-525.
  • 8Pearce KA, Furberg CD, Psaty BM, et al. Cost-mininization and the number need to treat in uncomplicated hypertension. Am J Hypertens,1998, 11:618-629.
  • 9Ramsey SD, Neil N, Sullivan SD, et al. An economic evaluation of the JNC hypertension guidelines using data from randomized controlled trial. Am Board Fam Prac, 1999, 12: 105-114.
  • 10Elliott WJ, Weir DR, Black HR. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Arch Intern Med, 2000, 160: 1277-1283.

共引文献2703

同被引文献90

引证文献16

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部